How can I get covid-19 treatment online in Hawaii?
Hawaii residents on any island can book a same-day video visit with Parth Bhavsar, MD — board-certified Family Medicine — without a flight to Oʻahu. TeleDirectMD holds an active Hawaii medical license (MD-26646-0) issued by the Hawaii Medical Board, verifiable through the state's MyPVL license search. Hawaii's geography means that for many residents of Hawaiʻi Island, Maui, Molokaʻi, Lanaʻi, and Kauaʻi, seeing a specialist or even reaching urgent care has historically meant an inter-island flight to Oʻahu — a same-day Hawaii telehealth visit removes that trip entirely for conditions appropriate for video evaluation. A visit costs $79 flat self-pay, with no insurance complexity and no surprise billing. HSA and FSA cards are accepted. Adults 18 and older physically located anywhere in the state — Oʻahu, Hawaiʻi Island, Maui County, or Kauaʻi — are eligible, including visitors currently in Hawaii.
COVID-19 Treatment via telehealth in Hawaii:
TeleDirectMD offers same-day video visits with a board-certified MD for covid-19 in Hawaii, starting at $79. A physician evaluates your symptoms, confirms the diagnosis, and sends a prescription to your local pharmacy — no waiting room required.
COVID-19 · Online Treatment in Hawaii
COVID-19 Treatment in Hawaii (Mild to Moderate)
Hawaii adult care by secure video visit, self pay option starting at $79, MD-only, insurance is not required.
Yes — adults (18+) in Hawaii with COVID-19 symptoms can be treated online. A board-certified MD reviews your symptoms, risk factors, and medication list by secure video and, per February 2026 CDC guidance, prescribes nirmatrelvir/ritonavir (Paxlovid) within 5 days of onset if you have risk factors for severe disease, or supportive care like acetaminophen for milder illness. Visit price: $79 flat, no insurance required. Shortness of breath at rest, chest pressure, or confusion needs ER care, not telehealth.
COVID-19 remains a treatable outpatient illness when antiviral therapy is started early. The CDC outpatient treatment guidelines (February 2026) recommend nirmatrelvir/ritonavir (Paxlovid) as first-line oral antiviral therapy for adults with mild to moderate COVID-19 who have risk factors for severe disease, initiated within 5 days of symptom onset. In clinical trials, Paxlovid reduced hospitalization and death by 86 percent in unvaccinated high-risk patients. The CDC recommends treatment consideration for anyone age 50 and older, as well as adults with multiple comorbidities, immunocompromised status, or incomplete vaccination. Supportive care with rest, hydration, and over-the-counter symptom management remains appropriate for mild illness in patients without risk factors for progression. TeleDirectMD uses a safety-first telehealth approach that screens for red flags including difficulty breathing, persistent chest pain or pressure, confusion, inability to stay awake, and cyanosis before determining whether outpatient treatment by video visit is appropriate. If the clinical picture supports uncomplicated mild to moderate COVID-19 without red flags, guideline-based treatment including Paxlovid when indicated may be reasonable by video, while adults with severe illness are directed to emergency care. This page is for adults located in Hawaii, including Honolulu, Pearl City, Hilo, Kailua, Waipahu, Kaneohe, Mililani Town, Kahului, Ewa Beach, Kapolei, and surrounding areas.
Quick navigation:
- Self pay option starting at $79
- MD-only care (no mid-levels)
- Insurance is not required
- Licensed telehealth care for patients located in Hawaii at the time of the visit
Last reviewed on 2026-09-12 by Parth Bhavsar, MD
ICD-10 commonly used: U07.1, J12.82, or M35.81 (final coding depends on clinical details)
Online MD-Only COVID-19 Care in Hawaii
flat self-pay · insurance not required
- Evaluation for COVID-19 symptoms and risk factors for severe disease
- Red-flag screening for respiratory distress and complications
- Paxlovid prescriptions when clinically appropriate and within treatment window
- Clear follow-up steps and escalation rules
Adults 18+ only. TeleDirectMD is not an emergency service. Go to the ER now for difficulty breathing or shortness of breath, persistent chest pain or pressure, confusion or inability to stay awake, pale gray or blue-colored skin lips or nail beds (cyanosis), oxygen saturation below 94 percent, or any signs of severe illness. TeleDirectMD does not prescribe controlled substances.
COVID-19 Telehealth Eligibility Checklist for Hawaii
You are likely eligible for a TeleDirectMD video visit if ALL of these are true:
✓ You Are Eligible If
- You are 18 years old or older
- You are physically located in Hawaii at the time of the visit
- You have symptoms consistent with COVID-19 such as fever, cough, sore throat, body aches, fatigue, congestion, or loss of taste or smell
- You have tested positive for COVID-19 with a rapid antigen test or PCR, or have strong clinical suspicion based on symptoms and exposure
- You do not have difficulty breathing, persistent chest pain, confusion, or cyanosis
- Your symptoms began within the last 5 days (for Paxlovid eligibility)
- You are not experiencing severe illness requiring hospitalization
- Insurance is not required. A self pay option is available.
✗ You Are Not Eligible If
- You are under 18 years old
- You have difficulty breathing or shortness of breath at rest
- You have persistent chest pain or pressure
- You have confusion, altered mental status, or inability to stay awake
- You have pale, gray, or blue-colored skin, lips, or nail beds
- You have oxygen saturation below 94 percent
- You are unable to keep fluids down due to severe vomiting
- You have severe illness requiring hospitalization or IV treatment
If you have red-flag symptoms suggesting severe COVID-19, seek emergency care immediately. TeleDirectMD is not an emergency service.
How Online COVID-19 Treatment Works in Hawaii
Book your video visit
Insurance is not required. No referral needed. Many visits are available same day, depending on scheduling. Before your visit, note when symptoms started, your COVID test result, your vaccination status, and any chronic medical conditions or medications you take.
See a Hawaii licensed MD by video
We review your symptom timeline, severity, risk factors for severe disease, and current medications. The CDC recommends Paxlovid for eligible patients within 5 days of symptom onset. We determine whether your presentation fits mild to moderate COVID-19 appropriate for outpatient treatment or requires in-person evaluation.
Get a treatment plan and, if appropriate, a prescription
If Paxlovid is clinically appropriate, we send an e-prescription to common Hawaii pharmacies such as CVS Pharmacy, Walgreens, Walmart Pharmacy, Longs Drugs, Times Pharmacy. Many patients with mild illness and no risk factors benefit from supportive care alone. You receive clear follow-up steps regardless of treatment choice, including when to seek in-person care if symptoms worsen.
Hawaii Telehealth Regulations for Online COVID-19 Care
Hawaii Revised Statutes Section 453-1.3 authorizes telehealth as a valid mode of healthcare delivery across the Hawaiian Islands. Providers licensed in Hawaii may establish and maintain a provider-patient relationship via telehealth, and insurers are required to provide coverage parity for telehealth services.
Location matters: you must be physically in Hawaii during the visit. Insurance is not required. TeleDirectMD does not prescribe controlled substances.
TeleDirectMD vs Other Care Options for COVID-19 in Hawaii
Here is how TeleDirectMD compares to common settings for adult COVID-19 care in Hawaii:
| Care option | Typical cost | Wait time | Provider type | Best for |
|---|---|---|---|---|
| TeleDirectMD | Self pay option starting at $79 | Same day, often within hours | Board-certified MD only (no mid-levels) | Mild to moderate COVID-19 with risk-factor assessment, Paxlovid prescriptions when appropriate, and clear follow-up |
| Urgent Care | $150 to $300+ (before insurance) | 1 to 3 hours typical | MD, DO, PA, or NP | Moderate symptoms, need for on-site COVID testing, or uncertain diagnosis requiring physical exam |
| Emergency Room | $500 to $3,000+ (before insurance) | 2 to 6 hours typical | Emergency medicine MD or DO | Difficulty breathing, persistent chest pain, confusion, cyanosis, oxygen saturation below 94 percent, or any signs of severe COVID-19 |
| Primary Care | $100 to $250+ (varies) | 3 to 14 days typical | Family medicine or internal medicine MD or DO | Post-COVID follow-up, long COVID evaluation, vaccination planning, and management of underlying conditions |
| Infectious Disease Specialist | $200 to $500+ (varies) | Days to weeks (varies) | Infectious disease MD or DO | Immunocompromised patients, treatment-resistant COVID-19, complicated infections, or need for IV remdesivir |
Bottom line: TeleDirectMD is a strong fit for mild to moderate COVID-19 in adults with timely risk-factor assessment, Paxlovid prescriptions when appropriate, and direct MD evaluation.
Should I Use TeleDirectMD for COVID-19 in Hawaii? Decision Guide
Do you have any emergency or red-flag symptoms?
- Difficulty breathing or shortness of breath at rest
- Persistent chest pain or pressure
- Confusion, altered mental status, or inability to stay awake
- Pale, gray, or blue-colored skin, lips, or nail beds (cyanosis)
- Oxygen saturation below 94 percent
If yes, go to the ER now
If no, continue to Step 2
Are you 18+ and currently in Hawaii?
If yes, continue to Step 3
If no, use in-person care as appropriate
Do your symptoms fit mild to moderate COVID-19?
- Fever, cough, sore throat, body aches, or fatigue
- Loss of taste or smell, nasal congestion, or runny nose
- Positive COVID test or strong clinical suspicion from symptoms and exposure
- No difficulty breathing at rest, no persistent chest pain, no confusion, no cyanosis
If yes, continue to Step 4
If no or symptoms are severe, seek in-person evaluation or ER
You are likely appropriate for a TeleDirectMD video visit
TeleDirectMD can evaluate your COVID-19 symptoms, assess risk factors for severe disease, determine whether Paxlovid or supportive care is appropriate based on CDC guidelines, and prescribe medication when clinically indicated. If your symptoms suggest severe illness or a complication, we will direct you to the right level of in-person care.
What Does COVID-19 Treatment Cost in Hawaii?
Transparent options. Insurance is not required.
TeleDirectMD Video Visit
$79
$79 flat visit · no insurance required · Paxlovid may be free through government/insurance programs
- MD evaluation and red-flag screening
- Risk-factor assessment for severe COVID-19
- Guideline-based antiviral treatment decision
- Paxlovid prescription sent if clinically appropriate
- Clear follow-up steps and escalation instructions
Typical Cost Comparison
Common ranges people see before insurance. Actual costs vary.
Total cost is transparent: the $79 visit is often the main cost, since Paxlovid may be available at no charge through government programs or insurance, and OTC symptom-relief medications for milder cases typically cost only a few dollars.
No hidden fees. If medication is not clinically appropriate, you still receive a complete evaluation, guidance, and clear instructions on what level of care you need next.
What Is COVID-19?
COVID-19 is a respiratory illness caused by the SARS-CoV-2 virus. While most adults with COVID-19 experience mild to moderate symptoms, certain populations are at significantly higher risk for severe disease, hospitalization, and death. The CDC identifies key risk factors including age over 65, incomplete vaccination, immunocompromised status, and multiple chronic medical conditions.
Oral antiviral therapy with nirmatrelvir/ritonavir (Paxlovid) has been shown to reduce hospitalization and death by 86 percent in high-risk patients when started within 5 days of symptom onset. The CDC February 2026 outpatient guidelines recommend Paxlovid as first-line treatment for eligible adults with risk factors. Early treatment is critical because antiviral effectiveness declines significantly when started after the 5-day window.
TeleDirectMD focuses on timely evaluation of mild to moderate COVID-19 symptoms with risk-factor assessment and antiviral prescriptions when clinically appropriate, with careful screening to direct patients with severe illness or complications to emergency care.
Causes and Risk Factors
COVID-19 is caused by the SARS-CoV-2 virus, transmitted primarily through respiratory droplets and aerosols. While anyone can contract COVID-19, specific risk factors significantly increase the likelihood of severe disease and the need for antiviral treatment.
- Age over 65: substantially higher risk of severe disease, with risk increasing further after age 75. The CDC recommends treatment consideration for anyone age 50 and older
- Incomplete vaccination: unvaccinated or not up to date on recommended COVID-19 vaccinations increases risk of severe outcomes
- Immunocompromised status: patients with weakened immune systems from medication, transplant, cancer treatment, or primary immunodeficiency are at highest risk
- Multiple chronic conditions: risk increases with the number of comorbidities including obesity, diabetes, cardiovascular disease, chronic lung disease, and chronic kidney disease
- Chronic lung disease: asthma, COPD, and other respiratory conditions increase risk of severe COVID-19 pneumonia
- Cardiovascular disease: heart failure, coronary artery disease, and cardiomyopathy increase the risk of severe disease and cardiac complications
Not every patient with COVID-19 needs antiviral treatment. The CDC recommends antiviral therapy primarily for patients with risk factors for severe disease. Mild illness in otherwise healthy young adults typically resolves with supportive care alone.
Symptoms and Red Flags for COVID-19 in Hawaii
Use this table to understand which symptoms fit mild to moderate COVID-19 and which patterns suggest a need for urgent in-person or emergency evaluation.
| Symptom or situation | What it suggests | Telehealth appropriate? | Red flag requiring urgent in-person care |
|---|---|---|---|
| Fever, cough, sore throat, body aches, and fatigue | Typical mild to moderate COVID-19 | Often yes | If persistent high fever not responding to antipyretics |
| Loss of taste or smell with upper respiratory symptoms | Characteristic of COVID-19 infection | Often yes | Not typically a red flag on its own |
| Nasal congestion, runny nose, and headache | Mild COVID-19 or other viral URI | Often yes | If severe headache with high fever or neck stiffness |
| Mild shortness of breath with exertion only | Moderate COVID-19, may benefit from monitoring | Sometimes | If progressing or occurring at rest |
| Persistent cough with chest tightness | Moderate COVID-19, monitor for progression | Sometimes | If worsening or accompanied by difficulty breathing at rest |
| Difficulty breathing or shortness of breath at rest | Possible severe COVID-19 pneumonia | No | Emergency evaluation now |
| Persistent chest pain or pressure | Possible cardiac or pulmonary complication | No | Emergency evaluation now |
| Confusion, inability to stay awake, or cyanosis | Possible severe hypoxia or end-organ involvement | No | Emergency evaluation now |
Differential Diagnosis: COVID-19 vs Other Conditions
Several respiratory illnesses can present with symptoms similar to COVID-19 including fever, cough, sore throat, and fatigue. TeleDirectMD evaluates symptom patterns, test results, and exposure history to guide appropriate treatment decisions.
Sometimes Appropriate for Telehealth
- Mild to moderate COVID-19 with risk-factor assessment and Paxlovid evaluation
- COVID-19 with supportive care needs and no red flags
- Differentiation from influenza, common cold, or other viral URI
- Post-COVID symptom management and return-to-activity guidance
- Antibiotic stewardship when bacterial superinfection is not present
Often Requires In-Person Evaluation
- Severe COVID-19 with respiratory distress requiring supplemental oxygen
- COVID-19 pneumonia requiring chest imaging and monitoring
- Need for IV remdesivir infusion (requires infusion center)
- Immunocompromised patients with severe or prolonged infection
- Suspected multisystem inflammatory syndrome or cardiac complications
COVID-19 vs Influenza
COVID-19 and influenza share many symptoms including fever, cough, body aches, and fatigue. COVID-19 is more likely to cause loss of taste or smell and tends to have a longer incubation period (2 to 14 days vs 1 to 4 days for flu). Both have antiviral treatments that work best when started early. A positive COVID test confirms the diagnosis, though co-infection with both viruses is possible.
COVID-19 vs Common Cold
The common cold typically causes milder symptoms centered on nasal congestion, runny nose, and sore throat, while COVID-19 more often includes fever, significant fatigue, body aches, and loss of taste or smell. Colds rarely cause shortness of breath. A positive COVID test distinguishes the two, which matters because COVID-19 may benefit from antiviral treatment while colds do not.
If your symptoms do not match mild to moderate COVID-19 or any red flags are present, TeleDirectMD will direct you to urgent in-person care or the ER.
When Is a Video Visit Appropriate?
When a Video Visit Is Appropriate
- Positive COVID test or strong clinical suspicion with mild to moderate symptoms
- Symptom onset within the last 5 days (for Paxlovid eligibility)
- No difficulty breathing at rest or persistent chest pain
- No confusion, altered mental status, or cyanosis
- Not requiring supplemental oxygen or IV medication
- Located in Hawaii at time of visit
Red Flags Requiring In-Person or ER Care
- Difficulty breathing or shortness of breath at rest
- Persistent chest pain or pressure
- Confusion, altered mental status, or inability to stay awake
- Pale, gray, or blue-colored skin, lips, or nail beds (cyanosis)
- Oxygen saturation below 94 percent
- High fever not responding to antipyretics
- Severe dehydration with inability to keep fluids down
If any red-flag symptoms are present, seek emergency care immediately. TeleDirectMD is not an emergency service.
Treatment Options
The CDC February 2026 outpatient guidelines recommend nirmatrelvir/ritonavir (Paxlovid) as first-line oral antiviral therapy for adults with mild to moderate COVID-19 who have risk factors for severe disease, started within 5 days of symptom onset. Supportive care is appropriate for mild illness in patients without significant risk factors.
Paxlovid (nirmatrelvir/ritonavir) for eligible patients
Paxlovid is the recommended first-line oral antiviral for outpatient COVID-19. It is taken twice daily for 5 days and must be started within 5 days of symptom onset. It reduced hospitalization and death by 86 percent in unvaccinated high-risk patients in clinical trials. Paxlovid is contraindicated in severe kidney disease (eGFR below 30) and severe liver disease (Child-Pugh C), and has significant drug interactions due to CYP3A inhibition. Your MD will review your medications and medical history to determine eligibility.
Supportive care for mild illness
For patients with mild COVID-19 and no significant risk factors for severe disease, supportive care is appropriate. This includes rest, adequate hydration, acetaminophen or ibuprofen for fever and pain, dextromethorphan for cough, guaifenesin for chest congestion, and monitoring for symptom progression. Most mild cases resolve within 7 to 14 days.
When telehealth care is not enough
If symptoms worsen, if difficulty breathing develops, if oxygen saturation drops below 94 percent, or if the patient requires IV remdesivir (second-line treatment requiring an infusion center), in-person evaluation is needed. Patients with severe kidney or liver disease who cannot take Paxlovid may need referral for IV remdesivir. Monoclonal antibody therapy, when available, also requires infusion.
What TeleDirectMD Does Not Manage
- Severe COVID-19 requiring hospitalization or supplemental oxygen
- COVID-19 pneumonia requiring chest imaging and monitoring
- IV remdesivir treatment (requires infusion center)
- Monoclonal antibody infusions
- Multisystem inflammatory syndrome or cardiac complications of COVID-19
Common Medication Options
These are common options for adult outpatient COVID-19 treatment. The actual medication, dose, and duration are determined by the MD after reviewing your symptoms, risk factors, medications, and medical history. Paxlovid eligibility depends on timing, kidney function, liver function, and drug interactions.
| Medication | Typical dose | Duration | Key considerations |
|---|---|---|---|
| Nirmatrelvir/ritonavir (Paxlovid) | 300 mg/100 mg by mouth twice daily | 5 days | First-line oral antiviral per CDC 2026 guidelines. Must start within 5 days of symptom onset. Contraindicated in severe kidney disease (eGFR <30) and severe liver disease. Significant CYP3A drug interactions require medication review. |
| Acetaminophen (Tylenol) | 500 to 1000 mg by mouth every 4 to 6 hours as needed | As needed | For fever and pain relief. Do not exceed 3000 mg per day. Avoid in severe liver disease. |
| Ibuprofen (Advil, Motrin) | 200 to 400 mg by mouth every 4 to 6 hours as needed | As needed | For fever, pain, and body aches. Take with food. Avoid in kidney disease or active GI bleeding. |
| Dextromethorphan (Delsym, Robitussin DM) | 10 to 20 mg by mouth every 4 hours or 30 mg every 6 to 8 hours | As needed for cough | Over-the-counter cough suppressant. May cause drowsiness. Check for interactions with other medications. |
| Guaifenesin (Mucinex) | 200 to 400 mg by mouth every 4 hours | As needed for congestion | Over-the-counter expectorant to thin mucus and ease chest congestion. Drink plenty of fluids while using. |
| Pseudoephedrine (Sudafed) | 60 mg by mouth every 4 to 6 hours | Short-term as needed | For nasal congestion. Available behind the pharmacy counter. Avoid in uncontrolled hypertension or cardiovascular disease. |
| Fluids and electrolytes | Adequate oral hydration throughout illness | Throughout illness | Critical supportive care. Oral rehydration solutions may help if appetite is poor. Seek emergency care if unable to keep fluids down. |
Important: Example regimens only. The actual medication, dosing, and duration are determined by the MD after reviewing your symptoms, risk factors, medications, and medical history. Paxlovid has significant drug interactions and is not appropriate for all patients. TeleDirectMD does not prescribe controlled substances.
Home Care, Recovery Timeline, Prevention, and Follow-up
Recovery Timeline and What to Do Now
- Most mild to moderate COVID-19 improves within 7 to 14 days
- If prescribed Paxlovid, complete the full 5-day course even if you feel better
- Isolate from others per current CDC guidelines to prevent transmission
- Rest and stay well hydrated with water, broth, and electrolyte drinks
- Monitor your oxygen saturation with a pulse oximeter if available
What to Watch For Over the Next 24 to 72 Hours
- Worsening shortness of breath, especially at rest or with minimal activity
- Persistent chest pain or pressure that does not resolve
- Confusion, difficulty staying awake, or altered mental status
- Pale, gray, or blue-colored skin, lips, or nail beds
- High fever not responding to acetaminophen or ibuprofen
- Inability to keep fluids down due to severe nausea or vomiting
Prevention and Follow-up
- If symptoms worsen or do not improve within 48 to 72 hours, contact your provider or seek in-person care
- Stay up to date on recommended COVID-19 vaccinations per CDC guidance
- Practice good hand hygiene and respiratory etiquette during illness
- If symptoms persist beyond 4 weeks, consider evaluation for post-COVID conditions (long COVID) with your primary care provider
- If any red-flag symptoms develop at any time, seek emergency care immediately
When Not to Use TeleDirectMD for COVID-19 in Hawaii
TeleDirectMD is designed for mild to moderate COVID-19 symptoms. We are direct about when telehealth is not appropriate.
You Should Not Use TeleDirectMD If
- You are under 18 years old
- You have difficulty breathing or shortness of breath at rest
- You have persistent chest pain or pressure
- You have confusion, altered mental status, or inability to stay awake
- You have pale, gray, or blue-colored skin, lips, or nail beds (cyanosis)
- You have oxygen saturation below 94 percent
- You need IV remdesivir or monoclonal antibody infusion
- You are not physically in Hawaii at the time of visit
Alternative Care Options
- Emergency room: difficulty breathing, persistent chest pain, confusion, cyanosis, oxygen saturation below 94 percent, or any signs of severe COVID-19
- Urgent care: moderate symptoms needing on-site COVID testing, uncertain diagnosis, or when physical exam and pulse oximetry are needed
- Infectious disease specialist: immunocompromised patients, treatment failure, need for IV remdesivir, or complicated COVID-19 infections
- Primary care: post-COVID follow-up, long COVID evaluation, vaccination planning, and management of underlying chronic conditions
Practicing in Hawaii
Parth Bhavsar, MD — board-certified Family Medicine — holds an active Hawaii medical license (MD-26646-0), issued February 11, 2026, by the Hawaii Medical Board, operating under the Hawaii Department of Commerce and Consumer Affairs (DCCA), Professional and Vocational Licensing Division. Telehealth practice in Hawaii is governed by Hawaii Revised Statutes §453-1.3 (Practice of Telehealth), which authorizes establishing a physician-patient relationship via telehealth and sets prescribing standards. Hawaii patients may independently verify Dr. Bhavsar's license through the state's MyPVL public license search. The license expires January 31, 2028. NPI: 1104323203.
TeleDirectMD serves adults located anywhere in Hawaii across all four counties. Honolulu County — coextensive with the island of Oʻahu — holds about 69% of the state's population and includes Honolulu, Pearl City, Kailua, Waipahu, Kaneohe, Mililani Town, Ewa Beach, and Kapolei. Hawaiʻi County, coextensive with Hawaiʻi Island (the Big Island), is the state's fastest-growing county and includes Hilo and Kailua-Kona; it is also where the large majority of Hawaii's rat lungworm cases and nearly all vog exposure from Kīlauea are concentrated. Maui County covers Maui (including Kahului), Molokaʻi, and Lānaʻi. Kauaʻi County covers Kauaʻi and Niʻihau. Specialist and urgent-care access is meaningfully thinner on Hawaiʻi Island, Maui County, and Kauaʻi than on Oʻahu, which is the primary reason neighbor-island residents have historically needed to fly to Honolulu for care that a same-day telehealth visit can now handle without leaving the island.
Hawaii's health landscape is shaped by geography as much as climate. Rat lungworm disease (neuroangiostrongyliasis), caused by the parasite Angiostrongylus cantonensis, is endemic on all the main Hawaiian islands and is tracked by the Hawaii Department of Health; from 2014 through late 2025, the state recorded 90 lab-confirmed and 12 probable cases, with about 76% on Hawaiʻi Island, 13% in Maui County, 7% in Honolulu County, and 4% in Kauaʻi County. It typically follows ingestion of raw or undercooked snails, slugs, or contaminated produce, and presents with severe headache and neck stiffness — a red flag that requires in-person evaluation, not telehealth. On Hawaiʻi Island specifically, vog — volcanic smog produced when sulfur dioxide from Kīlauea reacts with the atmosphere — is a well-documented, ongoing respiratory hazard tracked by the Hawaii Department of Health and the American Lung Association in Hawaiʻi; it worsens asthma and COPD symptoms and is most concentrated around Kailua-Kona and the volcano's downwind path. Hawaii's tropical climate keeps pollen-driven seasonal allergies comparatively mild relative to the mainland, but humidity and mold exposure are a more common local trigger for allergic and respiratory symptoms.
TeleDirectMD operates self-pay only in Hawaii — no commercial insurance, no QUEST Integration Medicaid plan, no Medicare. Every Hawaii visit is $79 flat self-pay, paid at booking, with no hidden fees or follow-up bills. HSA and FSA debit cards are accepted. Hawaii's commercially insured market is dominated by Hawaii Medical Service Association (HMSA) and Kaiser Permanente (Oʻahu and Maui only); TeleDirectMD is not in-network with either. Hawaii patients with commercial insurance may still book a TeleDirectMD visit at the $79 flat rate and submit the receipt to their plan for possible out-of-network reimbursement, though TeleDirectMD does not guarantee reimbursement and does not file claims on a patient's behalf. QUEST Integration (Hawaii Medicaid) beneficiaries — enrolled with AlohaCare, HMSA QUEST, Kaiser Permanente QUEST, 'Ohana Health Plan, or UnitedHealthcare Community Plan — should contact their plan to find an in-network telehealth provider.
COVID-19 Treatment FAQs for Hawaii
Can I get treatment for COVID-19 online in Hawaii?
Yes, if you are an adult 18+ located in Hawaii and your symptoms are mild to moderate without red flags such as difficulty breathing, chest pain, or confusion. TeleDirectMD can evaluate your symptoms, assess your risk factors for severe disease, and prescribe Paxlovid when clinically appropriate.
How much does online COVID-19 treatment cost in Hawaii?
TeleDirectMD offers a transparent self pay option starting at $79 for an adult video visit in Hawaii. Insurance is not required. Prescription costs at your pharmacy are separate. Paxlovid may be available at reduced cost through insurance or government programs.
Do I need Paxlovid for COVID-19?
Not everyone with COVID-19 needs Paxlovid. The CDC recommends antiviral treatment primarily for adults with risk factors for severe disease including age over 50, immunocompromised status, chronic medical conditions, and incomplete vaccination. Mild illness in healthy young adults typically resolves with supportive care alone. Your MD will assess your individual risk factors.
Who qualifies for Paxlovid?
Paxlovid is appropriate for adults with mild to moderate COVID-19 and risk factors for severe disease when started within 5 days of symptom onset. It is contraindicated in severe kidney disease (eGFR below 30) and severe liver disease. It has significant drug interactions that must be reviewed before prescribing. Your MD will evaluate your kidney function, liver function, and current medications.
Do I need a COVID test before a telehealth visit?
A positive COVID test (rapid antigen or PCR) strengthens the clinical picture and supports prescribing decisions, especially for Paxlovid. TeleDirectMD recommends testing before your visit if possible. At-home rapid antigen tests are widely available. However, a strong clinical history with characteristic symptoms and known exposure may also guide treatment decisions.
When should I go to the ER for COVID-19?
Seek emergency care immediately for difficulty breathing or shortness of breath at rest, persistent chest pain or pressure, confusion or inability to stay awake, pale gray or blue skin or lips or nail beds, oxygen saturation below 94 percent, or high fever not responding to over-the-counter medications. These signs suggest severe illness requiring in-person emergency evaluation.
Does Hawaii allow telemedicine for COVID-19 treatment?
Yes. Hawaii allows licensed professionals to provide telemedicine within their scope when appropriate and according to accepted standards of care. You must be physically located in Hawaii at the time of the visit.
What if my COVID-19 symptoms worsen after the visit?
If symptoms worsen, especially if you develop difficulty breathing, chest pain, confusion, or any red-flag symptoms, seek emergency care immediately. If you have a gradual worsening without red flags, contact TeleDirectMD or your primary care provider for reassessment. Early deterioration within 48 to 72 hours of starting Paxlovid should prompt re-evaluation.
Can TeleDirectMD prescribe Paxlovid for COVID-19?
Yes, when clinically appropriate. Paxlovid requires a prescription and your MD will evaluate your symptoms, timing since symptom onset, risk factors, kidney and liver function, and current medications before prescribing. Not all patients are eligible due to drug interactions or contraindications.
How long does COVID-19 last?
Most mild to moderate COVID-19 cases improve within 7 to 14 days. Some patients experience lingering symptoms such as fatigue and cough for several weeks. If symptoms persist beyond 4 weeks, this may represent post-COVID conditions (long COVID) and should be evaluated by your primary care provider.
Do I need a positive COVID test before my telehealth visit in Hawaii?
A prior positive test is helpful but not always required — the MD can evaluate your symptoms and exposure history to determine likelihood of COVID-19 and whether Paxlovid or supportive care is appropriate. Testing recommendations may still be given during the visit.
How quickly do I need to start Paxlovid after COVID symptoms begin in Hawaii?
Paxlovid should be started within 5 days of symptom onset for the best chance of preventing severe illness, so a same-day video visit is important if you have risk factors. The MD will also check for drug interactions and kidney or liver function history before prescribing.
I live on Maui, Hawaiʻi Island, or Kauaʻi — do I need to fly to Oʻahu for this?
No. TeleDirectMD's video visits are available to adults physically located anywhere in Hawaii — Oʻahu, Hawaiʻi Island, Maui, Molokaʻi, Lānaʻi, or Kauaʻi. The visit happens over secure video from wherever you are; there's no inter-island flight required for conditions appropriate for telehealth evaluation.
Does TeleDirectMD accept HMSA or Kaiser Permanente in Hawaii?
No. TeleDirectMD is self-pay only in Hawaii and is not currently in-network with Hawaii Medical Service Association (HMSA), Kaiser Permanente, or any QUEST Integration Medicaid managed care plan. Every Hawaii visit is $79 flat, regardless of insurance status. You're welcome to submit the visit receipt to your plan for possible out-of-network reimbursement, though reimbursement isn't guaranteed.
I'm visiting Hawaii on vacation — can I still book a visit?
Yes. Hawaii Revised Statutes §453-1.3 requires only that you be physically located in Hawaii at the time of the visit, which covers visitors as well as residents. If you're currently on any Hawaiian island, you're eligible for a same-day video visit at the standard $79 self-pay rate.
Is telehealth legal for treating conditions like UTIs, sinus infections, or asthma flares in Hawaii?
Yes. Hawaii Revised Statutes §453-1.3 authorizes Hawaii-licensed physicians to establish a physician-patient relationship via telehealth and to prescribe electronically where clinically appropriate, without requiring a prior in-person visit for most conditions. Dr. Bhavsar holds an active Hawaii medical license (MD-26646-0) from the Hawaii Medical Board. The exception is prescribing opiates or certifying medical cannabis, which still requires an in-person consultation under the same statute — TeleDirectMD does not provide either.
I have a severe headache and neck stiffness after possibly eating unwashed produce — can I get evaluated by video?
No — this combination of symptoms should be evaluated in person, not by telehealth. Rat lungworm disease (neuroangiostrongyliasis) is endemic to all the Hawaiian Islands and is concentrated on Hawaiʻi Island, and severe headache with neck stiffness can be an early sign. If you have these symptoms, especially after eating raw produce, homemade juice, or kava that may not have been thoroughly washed, seek in-person medical evaluation right away rather than booking a video visit.
Are Hawaii telehealth visits covered at the same rate as in-person care if I do have insurance?
Hawaii's telehealth parity law (HRS §431:10A-116.3, extended through December 31, 2027 under Act 107 as amended) requires Hawaii-regulated commercial insurers to reimburse telehealth at parity with in-person care when a covered provider delivers the service. That parity requirement applies to your own insurer's in-network telehealth benefit — it does not apply to TeleDirectMD, since TeleDirectMD is not in-network with any Hawaii commercial payer and charges the same $79 flat rate to every patient regardless of insurance.
Need help today?
Insurance is not required. Adult-only video visits. MD-only care. Safety-first triage, guideline-based treatment decisions, and prescriptions only when appropriate.
More Hawaii Resources
All Conditions in HawaiiInsurance & PricingFAQsAll States We Serve
TeleDirectMD Telehealth Disclaimer
TeleDirectMD provides MD-only virtual urgent care for adults (18+) in Hawaii using secure video visits to evaluate COVID-19 symptoms, assess risk factors for severe disease, provide evidence-based guidance, and prescribe antiviral treatment when clinically appropriate. Insurance is not required. You must be physically located in Hawaii at the time of your video visit. TeleDirectMD does not prescribe controlled substances.
TeleDirectMD is not an emergency service and is not a replacement for emergency care during severe COVID-19 with respiratory distress, hypoxia, or other signs of critical illness. TeleDirectMD cannot provide COVID testing, IV remdesivir, monoclonal antibody infusions, or inpatient care. This service is intended for mild to moderate COVID-19 and is not a substitute for in-person evaluation when severe disease is suspected.
Online COVID-19 treatment in Hawaii. Paxlovid prescription online. COVID-19 telehealth evaluation by video visit.
Get COVID-19 Treatment in Other States
TeleDirectMD treats covid-19 via telehealth in 44 states + DC. If you are traveling, relocating, or helping a family member in another state, select below to find this treatment near them.
What does an online doctor visit in Hawaii cost?
TeleDirectMD's $79 flat rate is up to 3× cheaper than an in-person urgent care visit and ~11× cheaper than an uninsured ER visit. See verified 2026 cash-pay prices across every care setting.
Compare TeleDirectMD to other telehealth services
How much does an online doctor visit cost? · TeleDirectMD vs. Teladoc · All platform comparisons
Prescribing limits: before you book
Can TeleDirectMD prescribe IV medications or IM shots?
TeleDirectMD does not prescribe intravenous (IV) medications or intramuscular (IM) medications, except EpiPen (epinephrine auto-injector) refills when clinically appropriate. This includes IV fluids and infusions, and IM antibiotic or steroid shots. We cannot issue these prescriptions for administration at another clinic or by another provider.